as on January 23, 2026 at 4:01 pm IST
Day's Low
Day's High
4.85%
Downside
8.76%
Upside
52 Week's Low
52 Week's High
10.64%
Downside
107.62%
Upside
as on January 23, 2026 at 4:01 pm IST
Market Cap
₹235.61 Cr
Return on Equity (ROE)
23.03
PE Ratio (TTM)
0Return on capital employed (ROCE)
21.13
Beta (LTM)
0.76
P/B Ratio
3.76
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-40.59
EPS (TTM)
2.76
Sector
FMCG
Book Value
21.01
Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Indo US with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 235.61 | 121.57% | 0.00 | 5 | 50 | |
| NA | 0.21 | NA | 0.00 | NA | NA | |
| NA | 258.20 | 49.59% | 0.00 | 2 | 48 | |
| NA | 27.52 | 3.4% | 0.68 | -2 | 20 | |
| BUY | 12,011.48 | 106.59% | 0.64 | 611 | 8,681 |
Get share price movements and forecasts by analysts on Indo US.
Source: S&P Global Market Intelligence
Search interest for Indo US Bio-Tech Ltd Stock has decreased by -87% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Indo US.
Indo US Bio-Tech Ltd’s net profit fell -40.59% since last year same period to ₹3.00Cr in the Q3 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -13.04% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Indo US Bio-Tech Ltd has declared dividend of ₹0.25 per share on 21 Nov 2024 - translating a dividend yield of 0.21%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, INDOUS stock has moved up by 4.5%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 29.83% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Take Solutions Ltd has given 200.2% return, outperforming this stock by 244.7%
Against Peers
![]()
In the last 3 years, Vimta Labs Ltd has given 156.1% return, outperforming this stock by 151.2%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 70.17% of holdings in Dec 2025 quarter
| Organisation | Indo US Bio-Tech Ltd |
| Industry | FMCG |
| CEO | Jagdish Ajudia |
| E-voting on shares | Click here to vote |
Indo US share price today stands at ₹117.5 as on at the close of the market. Indo US share today touched a day high of ₹127.79 and a low of ₹111.8.
Indo US touched a 52 week high of ₹243.95 and a 52 week low of ₹105. Indo US share price today i.e. is closed at ₹117.5, which is -51.83% down from its 52 week high and 11.90% up from its 52 week low.
Indo US market capitalisation is ₹235.61 Cr as on .
To buy Indo US shares, you need to follow these steps:
Indo US trading volume is 82.66K as on . This means that 82.66K shares of Indo US were bought and sold on the stock market during today's trading session.